{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T15:13:47Z","timestamp":1794842027359,"version":"4.9.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Interleukin (IL)-11 evolved as part of the innate immune response. In the human lung, IL-11 upregulation has been associated with viral infections and a range of fibroinflammatory diseases, including idiopathic pulmonary fibrosis. Transforming growth factor-beta (TGF\u03b2) and other disease factors can initiate an autocrine loop of IL-11 signaling in pulmonary fibroblasts, which, in a largely ERK-dependent manner, triggers the translation of profibrotic proteins. Lung epithelial cells also express the IL-11 receptor and transition into a mesenchymal-like state in response to IL-11 exposure. In mice, therapeutic targeting of IL-11 with antibodies can arrest and reverse bleomycin-induced pulmonary fibrosis and inflammation. Intriguingly, fibroblast-specific blockade of IL-11 signaling has anti-inflammatory effects, which suggests that lung inflammation is sustained, in part, through IL-11 activity in the stroma. Proinflammatory fibroblasts and their interaction with the damaged epithelium may represent an important but overlooked driver of lung disease. Initially thought of as a protective cytokine, IL-11 is now increasingly recognized as an important determinant of lung fibrosis, inflammation, and epithelial dysfunction.<\/jats:p>","DOI":"10.1038\/s12276-020-00531-5","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T04:11:16Z","timestamp":1606795876000},"page":"1871-1878","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["Interleukin-11 signaling underlies fibrosis, parenchymal dysfunction, and chronic inflammation of the airway"],"prefix":"10.1038","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8970-0932","authenticated-orcid":false,"given":"Benjamin","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Schafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"531_CR1","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.stem.2020.03.009","volume":"26","author":"MC Basil","year":"2020","unstructured":"Basil, M. C. et al. The cellular and physiological asis for lung repair and regeneration: past, present, and future. Cell Stem Cell 26, 482\u2013502 (2020).","journal-title":"Cell Stem Cell"},{"key":"531_CR2","doi-asserted-by":"crossref","unstructured":"George, P M. & Wells, A U. & Jenkins, R G. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir. Med. 8, 807\u2013815 (2020).","DOI":"10.1016\/S2213-2600(20)30225-3"},{"key":"531_CR3","first-page":"797","volume":"379","author":"DJ Lederer","year":"2018","unstructured":"Lederer, D. J. & Martinez, F. J. Idiopathic pulmonary fibrosis. N. Engl. J. Med. 379, 797\u2013798 (2018).","journal-title":"N. Engl. J. Med."},{"key":"531_CR4","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1183\/09031936.00185114","volume":"46","author":"J Hutchinson","year":"2015","unstructured":"Hutchinson, J., Fogarty, A., Hubbard, R. & McKeever, T. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur. Respir. J. 46, 795\u2013806 (2015).","journal-title":"Eur. Respir. J."},{"key":"531_CR5","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","volume":"389","author":"L Richeldi","year":"2017","unstructured":"Richeldi, L., Collard, H. R. & Jones, M. G. Idiopathic pulmonary fibrosis. Lancet 389, 1941\u20131952 (2017).","journal-title":"Lancet"},{"key":"531_CR6","doi-asserted-by":"publisher","first-page":"17074","DOI":"10.1038\/nrdp.2017.74","volume":"3","author":"FJ Martinez","year":"2017","unstructured":"Martinez, F. J. et al. Idiopathic pulmonary fibrosis. Nat. Rev. Dis. Prim. 3, 17074 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"531_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fmed.2018.00043","volume":"5","author":"O Desai","year":"2018","unstructured":"Desai, O., Winkler, J., Minasyan, M. & Herzog, E. L. The role of immune and inflammatory cells in idiopathic pulmonary fibrosis. Front. Med. 5, 43 (2018).","journal-title":"Front. Med."},{"key":"531_CR8","doi-asserted-by":"publisher","first-page":"7512","DOI":"10.1073\/pnas.87.19.7512","volume":"87","author":"SR Paul","year":"1990","unstructured":"Paul, S. R. et al. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc. Natl. Acad. Sci. USA 87, 7512\u20137516 (1990).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"531_CR9","first-page":"15","volume":"4","author":"YC Yang","year":"1992","unstructured":"Yang, Y. C. & Yin, T. Interleukin-11 and its receptor. Biofactors 4, 15\u201321 (1992).","journal-title":"Biofactors"},{"key":"531_CR10","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/S0021-9258(18)53974-0","volume":"268","author":"F D\u2019Alessandro","year":"1993","unstructured":"D\u2019Alessandro, F., Colamonici, O. R. & Nordan, R. P. Direct association of interleukin-6 with a 130-kDa component of the interleukin-6 receptor system. J. Biol. Chem. 268, 2149\u20132153 (1993).","journal-title":"J. Biol. Chem."},{"key":"531_CR11","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1016\/S0021-9258(19)67870-1","volume":"266","author":"S Rose-John","year":"1991","unstructured":"Rose-John, S. et al. Structural and functional studies on the human interleukin-6 receptor. Binding, cross-linking, internalization, and degradation of interleukin-6 by fibroblasts transfected with human interleukin-6-receptor cDNA. J. Biol. Chem. 266, 3841\u20133846 (1991).","journal-title":"J. Biol. Chem."},{"key":"531_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/08977199409001050","volume":"11","author":"B Modrell","year":"1994","unstructured":"Modrell, B., Liu, J., Miller, H. & Shoyab, M. LIF and OM directly interact with a soluble form of gp130, the IL-6 receptor signal transducing subunit. Growth Factors 11, 81\u201391 (1994).","journal-title":"Growth Factors"},{"key":"531_CR13","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1146\/annurev.immunol.15.1.797","volume":"15","author":"T Taga","year":"1997","unstructured":"Taga, T. & Kishimoto, T. Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15, 797\u2013819 (1997).","journal-title":"Annu. Rev. Immunol."},{"key":"531_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08977194.2019.1620227","volume":"37","author":"PM Nguyen","year":"2019","unstructured":"Nguyen, P. M., Abdirahman, S. M. & Putoczki, T. L. Emerging roles for Interleukin-11 in disease. Growth Factors 37, 1\u201311 (2019).","journal-title":"Growth Factors"},{"key":"531_CR15","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1189\/jlb.0410217","volume":"88","author":"JS Silver","year":"2010","unstructured":"Silver, J. S. & Hunter, C. A. gp130 at the nexus of inflammation, autoimmunity, and cancer. J. Leukoc. Biol. 88, 1145\u20131156 (2010).","journal-title":"J. Leukoc. Biol."},{"key":"531_CR16","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1086\/381715","volume":"74","author":"N Dagoneau","year":"2004","unstructured":"Dagoneau, N. et al. Null leukemia inhibitory factor receptor (LIFR) mutations in St\u00fcve-Wiedemann\/Schwartz-Jampel type 2 syndrome. Am. J. Hum. Genet. 74, 298\u2013305 (2004).","journal-title":"Am. J. Hum. Genet."},{"key":"531_CR17","doi-asserted-by":"publisher","first-page":"21861","DOI":"10.1074\/jbc.M113.461905","volume":"288","author":"T Komori","year":"2013","unstructured":"Komori, T., Tanaka, M., Senba, E., Miyajima, A. & Morikawa, Y. Lack of oncostatin M receptor \u03b2 leads to adipose tissue inflammation and insulin resistance by switching macrophage phenotype. J. Biol. Chem. 288, 21861\u201321875 (2013).","journal-title":"J. Biol. Chem."},{"key":"531_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/365027a0","volume":"365","author":"Y Masu","year":"1993","unstructured":"Masu, Y. et al. Disruption of the CNTF gene results in motor neuron degeneration. Nature 365, 27\u201332 (1993).","journal-title":"Nature"},{"key":"531_CR19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/ng0594-79","volume":"7","author":"R Takahashi","year":"1994","unstructured":"Takahashi, R. et al. A null mutation in the human CNTF gene is not causally related to neurological diseases. Nat. Genet. 7, 79\u201384 (1994).","journal-title":"Nat. Genet."},{"key":"531_CR20","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature24676","volume":"552","author":"S Schafer","year":"2017","unstructured":"Schafer, S. et al. IL-11 is a crucial determinant of cardiovascular fibrosis. Nature 552, 110\u2013115 (2017).","journal-title":"Nature"},{"key":"531_CR21","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1053\/j.gastro.2019.05.002","volume":"157","author":"AA Widjaja","year":"2019","unstructured":"Widjaja, A A. et al. Inhibiting interleukin 11 signaling reduces hepatocyte death and liver fibrosis, inflammation, and steatosis in mouse models of non-alcoholic steatohepatitis. Gastroenterology 157, 777\u2013792 (2019).","journal-title":"Gastroenterology"},{"key":"531_CR22","doi-asserted-by":"crossref","unstructured":"Ng, B. et al. Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis. Sci. Transl. Med. 11, eaaw1237 (2019).","DOI":"10.1126\/scitranslmed.aaw1237"},{"key":"531_CR23","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1016\/j.celrep.2019.05.077","volume":"27","author":"A Strikoudis","year":"2019","unstructured":"Strikoudis, A. et al. Modeling of fibrotic lung disease using 3D organoids derived from human pluripotent stem cells. Cell Rep. 27, 3709\u20133723.e5 (2019).","journal-title":"Cell Rep."},{"key":"531_CR24","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ajhg.2011.05.024","volume":"89","author":"P Nieminen","year":"2011","unstructured":"Nieminen, P. et al. Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth. Am. J. Hum. Genet. 89, 67\u201381 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"531_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/mgg3.28","volume":"1","author":"K Keupp","year":"2013","unstructured":"Keupp, K. et al. Mutations in the interleukin receptor IL11RA cause autosomal recessive Crouzon-like craniosynostosis. Mol. Genet. Genom. Med. 1, 223\u2013237 (2013).","journal-title":"Mol. Genet. Genom. Med."},{"key":"531_CR26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/jmedgenet-2016-104215","volume":"54","author":"KA Miller","year":"2017","unstructured":"Miller, K. A. et al. Diagnostic value of exome and whole genome sequencing in craniosynostosis. J. Med. Genet. 54, 260\u2013268 (2017).","journal-title":"J. Med. Genet."},{"key":"531_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/8904_2013_249","volume":"12","author":"R Papachristoforou","year":"2014","unstructured":"Papachristoforou, R., Petrou, P. P., Sawyer, H., Williams, M. & Drousiotou, A. A novel large deletion encompassing the whole of the galactose-1-phosphate uridyltransferase (GALT) gene and extending into the adjacent interleukin 11 receptor alpha (IL11RA) gene causes classic galactosemia associated with additional phenotypic abnormalities. JIMD Rep. 12, 91\u201398 (2014).","journal-title":"JIMD Rep."},{"key":"531_CR28","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/cge.13409","volume":"94","author":"E Brischoux-Boucher","year":"2018","unstructured":"Brischoux-Boucher, E. et al. IL11RA-related Crouzon-like autosomal recessive craniosynostosis in 10 new patients: resemblances and differences. Clin. Genet. 94, 373\u2013380 (2018).","journal-title":"Clin. Genet."},{"key":"531_CR29","doi-asserted-by":"crossref","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","DOI":"10.1530\/ey.17.14.3"},{"key":"531_CR30","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1182\/blood.V90.6.2148","volume":"90","author":"HH Nandurkar","year":"1997","unstructured":"Nandurkar, H. H. et al. Adult mice with targeted mutation of the interleukin-11 receptor (IL11Ra) display normal hematopoiesis. Blood 90, 2148\u20132159 (1997).","journal-title":"Blood"},{"key":"531_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.celrep.2018.09.005","volume":"25","author":"M Agthe","year":"2018","unstructured":"Agthe, M. et al. Mutations in craniosynostosis patients cause defective interleukin-11 receptor maturation and drive craniosynostosis-like disease in mice. Cell Rep. 25, 10\u201318.e5 (2018).","journal-title":"Cell Rep."},{"key":"531_CR32","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/j.1742-4658.2005.04544.x","volume":"272","author":"T Wang","year":"2005","unstructured":"Wang, T., Holland, J. W., Bols, N. & Secombes, C. J. Cloning and expression of the first nonmammalian interleukin-11 gene in rainbow trout Oncorhynchus mykiss. FEBS J. 272, 1136\u20131147 (2005).","journal-title":"FEBS J."},{"key":"531_CR33","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.3389\/fimmu.2018.03054","volume":"9","author":"E Wangkahart","year":"2018","unstructured":"Wangkahart, E., Secombes, C. J. & Wang, T. Studies on the use of flagellin as an immunostimulant and vaccine adjuvant in fish aquaculture. Front. Immunol. 9, 3054 (2018).","journal-title":"Front. Immunol."},{"key":"531_CR34","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s00705-014-2011-9","volume":"159","author":"L Xu","year":"2014","unstructured":"Xu, L., Podok, P., Xie, J. & Lu, L. Comparative analysis of differential gene expression in kidney tissues of moribund and surviving crucian carp (Carassius auratus gibelio) in response to cyprinid herpesvirus 2 infection. Arch. Virol. 159, 1961\u20131974 (2014).","journal-title":"Arch. Virol."},{"key":"531_CR35","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1172\/JCI118514","volume":"97","author":"O Einarsson","year":"1996","unstructured":"Einarsson, O., Geba, G. P., Zhu, Z., Landry, M. & Elias, J. A. Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J. Clin. Invest. 97, 915\u2013924 (1996).","journal-title":"J. Clin. Invest."},{"key":"531_CR36","doi-asserted-by":"publisher","first-page":"22261","DOI":"10.1016\/S0021-9258(17)31785-4","volume":"269","author":"JA Elias","year":"1994","unstructured":"Elias, J. A. et al. Epithelial interleukin-11. Regulation by cytokines, respiratory syncytial virus, and retinoic acid. J. Biol. Chem. 269, 22261\u201322268 (1994).","journal-title":"J. Biol. Chem."},{"key":"531_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021878","volume":"6","author":"MA Kapina","year":"2011","unstructured":"Kapina, M. A. et al. Interleukin-11 drives early lung inflammation during Mycobacterium tuberculosis infection in genetically susceptible mice. PLoS One 6, e21878 (2011).","journal-title":"PLoS One"},{"key":"531_CR38","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/infdis\/jiw176","volume":"214","author":"G Shepelkova","year":"2016","unstructured":"Shepelkova, G., Evstifeev, V., Majorov, K., Bocharova, I. & Apt, A. Therapeutic effect of recombinant mutated interleukin 11 in the mouse model of Tuberculosis. J. Infect. Dis. 214, 496\u2013501 (2016).","journal-title":"J. Infect. Dis."},{"key":"531_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0221029","volume":"14","author":"KE Traber","year":"2019","unstructured":"Traber, K. E. et al. Roles of interleukin-11 during acute bacterial pneumonia. PLoS One 14, e0221029 (2019).","journal-title":"PLoS One"},{"key":"531_CR40","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S0091-6749(00)90070-8","volume":"105","author":"E Minshall","year":"2000","unstructured":"Minshall, E. et al. IL-11 expression is increased in severe asthma: association with epithelial cells and eosinophils. J. Allergy Clin. Immunol. 105, 232\u2013238 (2000).","journal-title":"J. Allergy Clin. Immunol."},{"key":"531_CR41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1465-9921-14-34","volume":"14","author":"S Al-Muhsen","year":"2013","unstructured":"Al-Muhsen, S. et al. Th17 cytokines induce pro-fibrotic cytokines release from human eosinophils. Respir. Res. 14, 34 (2013).","journal-title":"Respir. Res."},{"key":"531_CR42","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1067\/mai.2001.117929","volume":"108","author":"S Molet","year":"2001","unstructured":"Molet, S. et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 108, 430\u2013438 (2001).","journal-title":"J. Allergy Clin. Immunol."},{"key":"531_CR43","doi-asserted-by":"publisher","first-page":"L804","DOI":"10.1152\/ajplung.90607.2008","volume":"296","author":"M Kawaguchi","year":"2009","unstructured":"Kawaguchi, M. et al. IL-17F-induced IL-11 release in bronchial epithelial cells via MSK1-CREB pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 296, L804\u2013L810 (2009).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"531_CR44","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/elps.200305773","volume":"25","author":"W Klein","year":"2004","unstructured":"Klein, W. et al. A promotor polymorphism in the Interleukin 11 gene is associated with chronic obstructive pulmonary disease. Electrophoresis 25, 804\u2013808 (2004).","journal-title":"Electrophoresis"},{"key":"531_CR45","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1172\/JCI119792","volume":"100","author":"P Ray","year":"1997","unstructured":"Ray, P. et al. Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes. J. Clin. Invest. 100, 2501\u20132511 (1997).","journal-title":"J. Clin. Invest."},{"key":"531_CR46","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1165\/rcmb.2010-0462OC","volume":"45","author":"SM Ruwanpura","year":"2011","unstructured":"Ruwanpura, S. M. et al. Interleukin-6 promotes pulmonary emphysema associated with apoptosis in mice. Am. J. Respir. Cell Mol. Biol. 45, 720\u2013730 (2011).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"531_CR47","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s12276-019-0371-7","volume":"52","author":"H Chen","year":"2020","unstructured":"Chen, H. et al. TGF-\u03b21\/IL-11\/MEK\/ERK signaling mediates senescence-associated pulmonary fibrosis in a stress-induced premature senescence model of Bmi-1 deficiency. Exp. Mol. Med. 52, 130\u2013151 (2020).","journal-title":"Exp. Mol. Med."},{"key":"531_CR48","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1172\/JCI119113","volume":"98","author":"W Tang","year":"1996","unstructured":"Tang, W. et al. Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction. J. Clin. Invest. 98, 2845\u20132853 (1996).","journal-title":"J. Clin. Invest."},{"key":"531_CR49","doi-asserted-by":"publisher","first-page":"8S","DOI":"10.1378\/chest.116.suppl_1.8S","volume":"116","author":"AB Waxman","year":"1999","unstructured":"Waxman, A. B. et al. Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation. Chest 116, 8S\u20139S (1999).","journal-title":"Chest"},{"key":"531_CR50","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/jlb.66.1.151","volume":"66","author":"AB Lentsch","year":"1999","unstructured":"Lentsch, A. B. et al. Regulatory effects of interleukin-11 during acute lung inflammatory injury. J. Leukoc. Biol. 66, 151\u2013157 (1999).","journal-title":"J. Leukoc. Biol."},{"key":"531_CR51","first-page":"L861","volume":"277","author":"BC Sheridan","year":"1999","unstructured":"Sheridan, B. C. et al. Interleukin-11 attenuates pulmonary inflammation and vasomotor dysfunction in endotoxin-induced lung injury. Am. J. Physiol. 277, L861\u2013L867 (1999).","journal-title":"Am. J. Physiol."},{"key":"531_CR52","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.4049\/jimmunol.174.4.2305","volume":"174","author":"Q Chen","year":"2005","unstructured":"Chen, Q. et al. IL-11 receptor alpha in the pathogenesis of IL-13-induced inflammation and remodeling. J. Immunol. 174, 2305\u20132313 (2005).","journal-title":"J. Immunol."},{"key":"531_CR53","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1165\/rcmb.2008-0053OC","volume":"39","author":"CG Lee","year":"2008","unstructured":"Lee, C. G. et al. Endogenous IL-11 signaling is essential in Th2- and IL-13-induced inflammation and mucus production. Am. J. Respir. Cell Mol. Biol. 39, 739\u2013746 (2008).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"531_CR54","doi-asserted-by":"publisher","unstructured":"Widjaja, A. A. et al. Redefining interleukin 11 as a regeneration-limiting hepatotoxin. http:\/\/www.bioRxiv.org\/content\/10.1101\/830018v1, https:\/\/doi.org\/10.1101\/830018 (2019).","DOI":"10.1101\/830018"},{"key":"531_CR55","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1465-9921-14-80","volume":"14","author":"GE Lindahl","year":"2013","unstructured":"Lindahl, G. E. et al. Microarray profiling reveals suppressed interferon stimulated gene program in fibroblasts from scleroderma-associated interstitial lung disease. Respir. Res. 14, 80 (2013).","journal-title":"Respir. Res."},{"key":"531_CR56","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1165\/rcmb.2013-0310OC","volume":"52","author":"Y Bauer","year":"2015","unstructured":"Bauer, Y. et al. A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 52, 217\u2013231 (2015).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"531_CR57","volume":"4","author":"Y Geng","year":"2019","unstructured":"Geng, Y. et al. PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis. JCI Insight 4, e125326 (2019).","journal-title":"JCI Insight"},{"key":"531_CR58","first-page":"1424","volume":"54","author":"I Roger","year":"2019","unstructured":"Roger, I., Estornut, C., Ballester, B., Milara, J. & Cortijo, J. Role of IL-11 in vascular function of pulmonary fibrosis patients. Eur. Respir. J. 54, 1424 (2019).","journal-title":"Eur. Respir. J."},{"key":"531_CR59","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1172\/JCI200418847","volume":"113","author":"N Hashimoto","year":"2004","unstructured":"Hashimoto, N., Jin, H., Liu, T., Chensue, S. W. & Phan, S. H. Bone marrow\u2013derived progenitor cells in pulmonary fibrosis. J. Clin. Investig. 113, 243\u2013252 (2004).","journal-title":"J. Clin. Investig."},{"key":"531_CR60","doi-asserted-by":"publisher","first-page":"E1475","DOI":"10.1073\/pnas.1117988108","volume":"108","author":"JR Rock","year":"2011","unstructured":"Rock, J. R. et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc. Natl. Acad. Sci. USA 108, E1475\u2013E1483 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"531_CR61","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1136\/thx.50.9.984","volume":"50","author":"H Suganuma","year":"1995","unstructured":"Suganuma, H., Sato, A., Tamura, R. & Chida, K. Enhanced migration of fibroblasts derived from lungs with fibrotic lesions. Thorax 50, 984\u2013989 (1995).","journal-title":"Thorax"},{"key":"531_CR62","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1165\/rcmb.2002-0262OC","volume":"29","author":"YP Moodley","year":"2003","unstructured":"Moodley, Y. P. et al. Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am. J. Respir. Cell Mol. Biol. 29, 490\u2013498 (2003).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"531_CR63","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1165\/rcmb.2011-0237OC","volume":"46","author":"SK Madala","year":"2012","unstructured":"Madala, S. K. et al. MEK-ERK pathway modulation ameliorates pulmonary fibrosis associated with epidermal growth factor receptor activation. Am. J. Respir. Cell Mol. Biol. 46, 380\u2013388 (2012).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"531_CR64","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.4161\/cc.9.14.12268","volume":"9","author":"WD Hardie","year":"2010","unstructured":"Hardie, W. D. et al. Signaling pathways in the epithelial origins of pulmonary fibrosis. Cell Cycle 9, 2769\u20132776 (2010).","journal-title":"Cell Cycle"},{"key":"531_CR65","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.4049\/jimmunol.152.5.2421","volume":"152","author":"JA Elias","year":"1994","unstructured":"Elias, J. A. et al. IL-1 and transforming growth factor-beta regulation of fibroblast-derived IL-11. J. Immunol. 152, 2421\u20132429 (1994).","journal-title":"J. Immunol."},{"key":"531_CR66","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/jcb.20608","volume":"96","author":"L Gallelli","year":"2005","unstructured":"Gallelli, L. et al. Endothelin-1 induces proliferation of human lung fibroblasts and IL-11 secretion through an ET(A) receptor-dependent activation of MAP kinases. J. Cell. Biochem. 96, 858\u2013868 (2005).","journal-title":"J. Cell. Biochem."},{"key":"531_CR67","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1084\/jem.20102510","volume":"208","author":"Y Li","year":"2011","unstructured":"Li, Y. et al. Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. J. Exp. Med. 208, 1459\u20131471 (2011).","journal-title":"J. Exp. Med."},{"key":"531_CR68","doi-asserted-by":"publisher","first-page":"L1164","DOI":"10.1152\/ajplung.00220.2017","volume":"313","author":"D \u00c1lvarez","year":"2017","unstructured":"\u00c1lvarez, D. et al. IPF lung fibroblasts have a senescent phenotype. Am. J. Physiol. Lung Cell. Mol. Physiol. 313, L1164\u2013L1173 (2017).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"531_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14532","volume":"8","author":"MJ Schafer","year":"2017","unstructured":"Schafer, M. J. et al. Cellular senescence mediates fibrotic pulmonary disease. Nat. Commun. 8, 14532 (2017).","journal-title":"Nat. Commun."},{"key":"531_CR70","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.rmed.2009.04.014","volume":"103","author":"E Bargagli","year":"2009","unstructured":"Bargagli, E. et al. Oxidative stress in the pathogenesis of diffuse lung diseases: a review. Respir. Med. 103, 1245\u20131256 (2009).","journal-title":"Respir. Med."},{"key":"531_CR71","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/cphy.c190017","volume":"10","author":"E Otoupalova","year":"2020","unstructured":"Otoupalova, E. & Smith, S. & Cheng, G. & Thannickal, V J. Oxidative stress in pulmonary fibrosis.Compr. Physiol. 10, 509\u2013547 (2020).","journal-title":"Compr. Physiol."},{"key":"531_CR72","doi-asserted-by":"crossref","unstructured":"Katzen, J. & Beers, M F. Contributions of alveolar epithelial cell quality control to pulmonary fibrosis. J. Clin. Invest. 130, 5088\u20135099 (2020).","DOI":"10.1172\/JCI139519"},{"key":"531_CR73","doi-asserted-by":"crossref","unstructured":"Caporarello, N. et al. Vascular dysfunction in aged mice contributes to persistent lung fibrosis. Aging Cell 19, e13196 (2020).","DOI":"10.1111\/acel.13196"},{"key":"531_CR74","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1164\/rccm.201704-0784OC","volume":"197","author":"JM Parker","year":"2018","unstructured":"Parker, J. M. et al. A phase 2 randomized controlled study of Tralokinumab in subjects with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 197, 94\u2013103 (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"531_CR75","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","volume":"366","author":"Idiopathic Pulmonary Fibrosis Clinical Research Network.","year":"2012","unstructured":"Idiopathic Pulmonary Fibrosis Clinical Research Network. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N. Engl. J. Med. 366, 1968\u20131977 (2012).","journal-title":"N. Engl. J. Med."},{"key":"531_CR76","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41584-018-0112-7","volume":"14","author":"SG Dakin","year":"2018","unstructured":"Dakin, S. G. et al. Pathogenic stromal cells as therapeutic targets in joint inflammation. Nat. Rev. Rheumatol. 14, 714\u2013726 (2018).","journal-title":"Nat. Rev. Rheumatol."},{"key":"531_CR77","unstructured":"West, N. R. et al. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. Nat. Med. 23, 579\u2013589 (2017)."},{"key":"531_CR78","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","volume":"178","author":"CS Smillie","year":"2019","unstructured":"Smillie, C. S. et al. Intra- and inter-cellular rewiring of the human colon during ulcerative colitis. Cell 178, 714\u2013730.e22 (2019).","journal-title":"Cell"},{"key":"531_CR79","doi-asserted-by":"crossref","unstructured":"Ng, B. et al. Fibroblast-specific IL11 signaling drives chronic inflammation in murine fibrotic lung disease. FASEB J. 34, 11802\u201311815 (2020).","DOI":"10.1096\/fj.202001045RR"},{"key":"531_CR80","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S2213-2600(18)30508-3","volume":"7","author":"MKD Scott","year":"2019","unstructured":"Scott, M. K. D. et al. Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study. Lancet Respir. Med. 7, 497\u2013508 (2019).","journal-title":"Lancet Respir. Med."},{"key":"531_CR81","doi-asserted-by":"publisher","first-page":"1802441","DOI":"10.1183\/13993003.02441-2018","volume":"54","author":"C Morse","year":"2019","unstructured":"Morse, C. et al. Proliferating SPP1\/MERTK-expressing macrophages in idiopathic pulmonary fibrosis. Eur. Respir. J. 54, 1802441 (2019).","journal-title":"Eur. Respir. J."},{"key":"531_CR82","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-med-041818-011649","volume":"71","author":"SA Cook","year":"2020","unstructured":"Cook, S. A. & Schafer, S. Hiding in plain sight: interleukin-11 emerges as a master regulator of fibrosis, tissue integrity, and stromal inflammation. Annu. Rev. Med. 71, 263\u2013276 (2020).","journal-title":"Annu. Rev. Med."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00531-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00531-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00531-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T05:49:30Z","timestamp":1697262570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-020-00531-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":82,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["531"],"URL":"https:\/\/doi.org\/10.1038\/s12276-020-00531-5","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"15 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S. A. Cook and S. Schafer are coinventors of the patent applications (WO2017103108, WO2017103108 A2, WO 2018\/109174 A2, and WO 2018\/109170 A2) for \u201cTreatment of fibrosis\u201d. S. A. Cook and S. Schafer are coinventors of the patent applications (GB1900811.9, GB 1902419.9, and GB1906597.8) for \u201cTreatment of hepatotoxicity, nephrotoxicity, and metabolic diseases\u201d. B. Ng, S. A. Cook, and S. Schafer are coinventors of the patent application (WO\/2019\/073057) for \u201cTreatment of SMC mediated disease\u201d. S. A. Cook and S. Schafer are cofounders and shareholders of Enleofen Bio Pte. Ltd., a company that develops anti-IL11 therapeutics.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}